{"schema_version":"secwatch.filing_event.v1","accession":"0001628280-24-052235","form_type":"8-K","ticker":"BLFS","cik":"0000834365","company_name":"BIOLIFE SOLUTIONS INC","filed_at":"2024-12-20T23:59:59+00:00","discovered_at":"2026-05-14T18:03:11.131096+00:00","generated_at":"2026-05-29T00:43:44.176472+00:00","sec_items":["5.02","9.01"],"event_type":"leadership","sentiment":"positive","materiality_score":0.6,"calibrated_materiality_score":0.6,"confidence":"high","headline":"BioLife Solutions appoints Tony J. Hunt (Repligen Chairman) to board effective Jan 2, 2025","bullets":["Tony J. Hunt, Executive Chairman of Repligen (Nasdaq: RGEN), appointed to BioLife board.","Appointment increases board size to six members; Hunt qualifies as independent under Nasdaq rules.","Hunt previously served as Repligen CEO (2015-2024) and President of Bioproduction at Life Technologies.","He will serve on the Audit Committee and receive standard non-employee director compensation.","Board cites Hunt's bioprocessing expertise to support BioLife's focus on cell and gene therapy tools."],"urls":{"canonical":"https://secwatch.observer/filing/0001628280-24-052235","json":"https://secwatch.observer/filing/0001628280-24-052235.json","markdown":"https://secwatch.observer/filing/0001628280-24-052235.md","text":"https://secwatch.observer/filing/0001628280-24-052235.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/834365/000162828024052235/0001628280-24-052235-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/834365/000162828024052235/blfs-20241216.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-29T00:43:44.176472+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}